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Introduction
Insulin resistance (IR) is a major risk factor for the development of type 2 diabetes (T2D) and people with IR and/or T2D have been found to have 2-4 fold greater risk of CVD with 80%
of people with T2D dying from CVD (Capewell et al. 2009 ). T2D prevalence is rising, with ~400 million global cases (projected to rise to ~600 million cases by 2035), it accounts for >10% of healthcare spending (International Diabetes Federation, 2013) . Lack of physical activity and excess weight are the main factors thought to be responsible for this high, and increasing, prevalence. For this reason, and to achieve many of the other health benefits, people are recommended to participate in 150 minutes of moderate or 75 minutes of vigorous intensity exercise per week.
Indeed, moderate intensity exercise (150 min/week) has been shown to be effective in reducing T2D to a greater extent than treatment with metformin (Knowler et al. 2002) . Sprint interval training (SIT) has emerged as a strategy that can improve exercise performance, glucose control, insulin sensitivity, mitochondrial capacity, endothelial function and reduce postprandial triacylglycerol in healthy individuals after as little as 2 weeks (Babraj et al. 2009; Burgomaster et al. 2005; Gabriel et al. 2012; Little et al. 2010; Tjønna et al. 2008) . A wealth of evidence demonstrates the health benefits of SIT, but inter-individual variation in responses implies interactions with genetics (Timmons et al. 2010 ) and requires investigation to optimise SIT interventions.
SIRTUIN1 and the enzymes crucial in generating the sirtuin cofactor, nicotinamide adenine dinucleotide (NAD), have recently been implicated in diet and age-induced pathogenesis of T2D (Dong 2012; Haigis and Sinclair 2010; Huynh et al. 2013) . The sirtuin/NAD system is D r a f t 5 also responsive to altered glucose regulation during the development of diet induced obesity (Drew et al 2016) . Increased physical activity is associated with beneficial effects on metabolic health that are associated with altered regulation of the sirtuin system (Koltai et al. 2010 ). Further research is necessary to decipher the components of the sirtuin system that respond to exercise interventions that improve metabolic health. The sirtuin/NAD system is compromised by interactions with individual genetics (Kilic et al. 2014 ) since all seven sirtuins (SIRT1-7) and NAD biosynthesis enzymes are subject to genetic variation. Sirtuins are dependent on an adequate supply of NAD cofactors for enzymatic activity to regulate cellular processes linking them to the energy status of cells via cellular generation of nicotinamide. NAD generation is dependent on dietary intake of tryptophan and bioavailable niacin, but importantly NAD can be regenerated, independent of diet, by activation of salvage pathways that are upregulated in response to exercise (Hubbard and Sinclair 2014) .
Recent technological advances present opportunities to predict health status and benefits conferred by lifestyle interventions using gene expression profiling of whole blood (Drew et al 2012) . Considering the difficulties in accessing target tissues in human subjects this presents a strategy warranting consideration for research to identify individual responses to diet and lifestyle interventions. Consequently, our lab has been conducting studies to determine the feasibility of whole blood gene expression profiling to identify responses to interventions in humans (Drew et al 2014) . This led to identification of variable levels of SIRT1 in human whole blood from apparently healthy individuals (Drew et al. 2014 , Andraos et al 2016 Thus the aim of this study was to determine changes in anthropometric and metabolic measures in response to SIT. Secondly, the study aimed to determine whether these changes were associated with modulation of the sirtuin/NAD system using human whole blood gene expression profiling. We hypothesised that improvements in outcome measures following SIT would be associated with specific changes in components of the sirutin/NAD system.
Materials and Methods

Study population
Twenty recreationally active, but not specifically trained (not engaged in physical training to increase strength, aerobic fitness, speed, fitness or skillful practice for a specific sport or activity), participants aged 18-35 years, non-smokers, free of cardiovascular, metabolic or haematological disorders were recruited. The study was approved by the University of Aberdeen College Ethical Review Board. All participants were fully informed of the aims, risks and discomfort associated with the investigation before providing written informed consent.
Pre-Experimental and Post Training Procedures
D r a f t
Participants were asked to complete a 4 day estimated food diary (2 weekdays and 2 weekend days, on 4 consecutive days) directly preceding the SIT intervention. Recorded food diary data was input into NetWISP dietary software analysis and patterns of daily food and nutrient intake were then determined, with specific reference to macronutrients and micronutrients associated with NAD generation (e.g. niacin). Participants were asked to maintain their habitual dietary intake and physical activity patterns for the duration of the study.
Participants attended the laboratory in the morning after an overnight fast (from 10pm the previous evening) having abstained from strenuous exercise, caffeine and alcohol for 24h.
Blood samples and the measurements detailed below were obtained no more than 1 week prior to the SIT intervention and 2 days after the final training session. Body mass and height were measured using standard scales and stadiometers. Subcutaneous body fat was measured at four points on the body (biceps, triceps, suprailiac and subscapular) to the nearest 0.2mm using skinfold callipers (Harpenden) and converted to body fat percentage using the equations of (Durnin and Womersley 1974) . Waist/hip ratio was assessed using a tape to measure hip and waist circumferences to the nearest 1cm. An oral glucose tolerance test 
Exercise Training
The SIT program was performed using a cycle ergometer and involved 3 sessions per week for 4 weeks. The participants warmed up for 3 mins at a workload of 50 Watts, followed by 4-6 (building from 4 to 6 over the first 6 sessions) maximal 30s sprints at a resistance equivalent to 7.5% of body mass with 3 minutes unloaded cycling between sets. This was followed by a 3 min cool down at 50 Watts. Participants were instructed to perform each sprint maximally with encouragement given during each sprint. The intensity of each bout
was not recorded. Once carrying out 6 sprints each session lasted 24 mins. Participants performed this protocol three times each week for a 4-week period and all sessions were supervised.
Glucose and Insulin Analysis
Glucose (Human Glucose, Randox, UK) and insulin (Human Insulin, Mercodia UK) were assayed in plasma using commercially available kits according to the manufacturer's instructions and spectrophotometers, a Camspec M330B and a Biotek, Synergy HT multimode microplate reader respectively.
The AUC for both glucose and insulin concentrations during the OGTT were calculated using the trapezoid rule. Insulin sensitivity was estimated using the Cederholm index (Equation 
Lipid profiling
Lipid profiles (total cholesterol, HDL, LDL, triglycerides, Non-HDL and LDL: HDL ratio) of baseline (pre and post SIT) were measured from whole blood samples using commercially available kits (Alere Cholestech LDX® Lipid Profile Cassettes), in accordance with manufacturer's instructions.
Blood expression profiling of sirtuin and NAD biosynthetic enzyme genes
Total RNA was extracted from human whole blood samples collected at baseline (pre and post SIT) and 60 min post OGTT in PAXgene® blood RNA tubes (PreAnalytiX GmbH) (2.5ml) using a PAXgene Blood RNA Kit (Qiagen, Crawley, UK), incorporating DNase digestion. RNA quality was assessed using a NanoDrop Spectrophotometer (NanoDrop Technologies, LabTech International, UK) and the Agilent Bioanalyser (Agilent Technologies, Bracknell, UK). Whole blood total RNA (50 ng) was assayed for sirtuin and NAD biosynthetic enzyme gene targets using the GenomeLab™ GeXP Genetic Analysis System (Beckman Coulter) and our in-house custom designed assay, the hSIRTNADPlex.
The hSIRTNADPlex incorporates 25 gene targets, including all 7 mammalian sirtuin genes (SIRT1-7), 15 enzymes involved in conversion of tryptophan, niacin, the novel vitamin, nicotinamide riboside, and metabolic precursors to NAD, together with 3 reference genes and a synthetic reference messenger RNA transcript for measuring relative quantitation of gene D r a f t expression and reaction efficiencies respectively (Supplementary File S1). Details of the the GenomeLab System for design of in-house custom designed multiplex assays and application to conduct blood gene expression profiling have been published previously (Drew et al. 2011; Drew et al. 2014) and are described in Supplementary File S2. Fragment analysis of the generated hSIRTNADPlex PCR products was conducted using the Beckman Coulter CEQ 8000 GeXP Genetic Analysis system. The raw data generated using the GenomeLab™ GeXP Series Software Suite v11.0 was then exported using the GeXP Fragment Analysis Module and normalized using the GeXP Data Tool.
NAD and NADP assay
NAD and NADP were assessed in whole blood (50ul) at baseline (pre and post SIT) using methods described by Jacobsen and Jacobsen (1997) with modifications as described by Creeke et al. 2007 ). Spectrophotometric readings were assayed using an MRX plate reader (Dynatech Laboratories).
Bradford Assay
Commercially available reagents (Bradford Reagent, PBS, BSA; Sigma-Aldrich® UK) and 96-well microtiter plates (F96 Maxisorp NUNC immunoplate, VWR) were used to determine total protein content of plasma samples pre and post SIT intervention using standard Bradford assay procedure. Absorbance was measured using a standard curve and plate reader (MRX plate reader, Dynatech Laboratories) at 595nm.
NAMPT and Vitamin B3
D r a f t Vitamin B3 and NAMPT concentrations were determined via commercially available enzyme-linked immunosorbent assay (ELISA) kits (RayBio® and MyBioSource®, USA)
according to the manufacturer's instructions. NAMPT concentrations were subsequently standardised against total protein content assessed by Bradford assay.
Statistics
Plasma glucose and insulin responses to the pre-training and post-training OGTTs were analysed using two-way repeated measures ANOVA with post hoc t-tests. Paired t-tests were used to assess significant changes in anthropometric measures, metabolic biomarkers, gene expression and other relevant markers from pre to post SIT intervention (p<0.05). Principal
Component Analysis (PCA) and Partial Least Squares (PLS) analyses were performed using SIMCA-P+ 12.0 software (MKS Instruments UK Ltd, Cheshire). PCA was conducted with normalised gene expression and PLS was performed using normalised gene expression data (Y) and anthropometric and metabolic marker data (X). Pearson correlations were calculated using SPSS.
Results
Study participants
Twenty individuals were recruited to participate in the study (13 males and 7 females) and all completed (100% attendance at sessions) the 4 week supervised SIT intervention. The mean ±SD age was 22.8 ±2.8 years, height was 1.77±0.11 m and weight was 73.6±14.3 kg.
D r a f t
Food diaries
Estimated daily macronutrient and niacin intakes were calculated from 14 of the 20 participants (7 female) that returned completed food diaries (Table 1 ). The data collected indicated mean macronutrient intakes within the normal range recommended intakes prior to study participation. The % of total daily energy ± SEM intakes were fat 33.6 ± 2.3, protein 17.8 ± 0.9 and carbohydrate 44.5 ± 2.5. Individual niacin intake was varied, with mean niacin intake 27.8 ± 3.1 mg/day, ranging from 14.84 -60.34 mg/day. Participants were asked to maintain their habitual dietary intake patterns for the duration of the SIT intervention.
Anthropometric data
Anthropometric measurements (n=20) pre and post SIT are shown (Table 2 ). Significant reductions in body mass (p=0.023) and body fat percentage (p=0.0004) were seen after SIT (Table 2) . No significant differences were observed in BMI (p=0.07) or waist:hip ratio (p=0.19) post SIT (Table 2) . However, review of individual responses to SIT indicated that there was inter-individual variation, with some, but not all participants responding favourably ( Figures 1A-D) .
Glucose, insulin and insulin sensitivity
Mean glucose, insulin (Table 3 ) and glucose concentrations following OGTT ( Figure 2A) were not significantly altered in response to SIT. Glucose area under the curve (AUC) did not significantly change post SIT (p=0.34 Figure 2B ).
Mean insulin AUC was also not significantly reduced (p=0.38) post SIT ( Figure 2C ).
However, despite the lack of significant decreases, mean insulin AUC change was -194. ) ( Figure 2D ). The mean insulin sensitivity increase following 4 weeks SIT was 2.62 ± 13.6mg.mUl -1
.min, but this was not significant (p=0.40) ( Figure 2E ). It was noted that 12 of the 20 participants had increased insulin sensitivity post SIT (range: +25.7mg.mUl .min) ( Figure 2F ).
Lipid profiling
Lipid profiles, total cholesterol (p=0.42), HDL (p=0.95), LDL (p=0.23), triglycerides (p=0.30), non HDL (0.44) and LDL: HDL ratios (p=0.63) were not significantly altered in response to SIT (n=19) ( Table 3 ) and a wide range of responses observed (data not shown).
Transcriptional responses of SIRT/NAD system to SIT
The hSIRTNADPlex gene expression profiles measured in whole blood total RNA (RIN values 7.0-9.3) pre and post SIT and post OGTT normalised to UBE2D2, established as a stably expressed transcript in blood using geNORM (Pattyn et al. 2003) , are shown ( Figure   3 ). Small, but significant changes in response to SIT and OGTT were observed (Figure 3 ). 
Vitamin B3 concentrations
Decreased mean plasma vitamin B3 concentrations following SIT and in response to the OGTT were not significant ( Figure 4A ) with a wide range of responses observed pre to post SIT levels (range: -1.22µmol.L -1 to +0.59µmol.L -1 ). Thirteen of the 20 participants had reduced levels of vitamin B3 post SIT ( Figure 4B ).
NAD: NADP ratio analysis
Whole blood (n=11) NAD (p=0.91, mean decrease 1.6 ± 50nmol.L -1 ) and NADP (p=0.07, mean increase of 21.8 ± 36.3nmol.L -1 ) levels did not significantly change post SIT. The NAD: NADP ratio was significantly reduced after 4 weeks of SIT (p=0.014) compared with baseline measures ( Figure 4C) , with a mean decrease of 0.34 ± 0.47 (range: -0.37 to +0.04) ( Figure 4D ). Figure 4E ). Inter-individual variation in NAMPT plasma concentrations were observed ranging from +0.051ng/mg and -0.043ng/mg ( Figure 4F ).
NAMPT concentration
Correlated SIRT/NAD gene expression and metabolic markers
Expression of NAMPT, CD38, ABCA1 and NMNAT1 were all positively correlated following SIT, while pre SIT expression was not (Table 4) Potential co-regulated expression of NAMPT, CD38, ABCA1 and NMNAT1 was further investigated by determining correlations with metabolic markers pre and post SIT. Notably, plasma glucose and cholesterols were associated with NAMPT and ABCA1 regulation.
NAMPT and ABCA1 were positively correlated with post SIT, but not pre SIT fasted glucose (NAMPT r = 0.636, p = 0.003; ABCA1, r = 0.466, p = 0.038) ( Table 5) . NAMPT and glucose AUC (r = 0.462, p = 0.04) were also positively correlated post SIT, but not pre SIT (Table 5) .
NAMPT was negatively correlated with LDL (r = -0.497, p = 0.03) ( Table 5) . NAMPT expression was also negatively associated with NAD: NADP ratio (r=-0.676, p=0.022) post SIT, but not pre SIT (Table 5) . anthropometric and metabolic marker data (X) ( Figure 5B ). The PLS plot identified body fat levels as a factor associated with clustering of female participants ( Figure 5B ). Glucose and insulin are positioned further from female participants indicating that these factors may also differ in male and female participants in response to SIT ( Figure 5B ). Notably, NAMPT and ABCA1 expression levels are closely associated with glucose and insulin levels ( Figure 5B) reflecting the identified positive correlation post SIT (Table 5 ) providing further indication that these genes are responsive to glucose and insulin ( Figure 4 ).
Principal Component and
Discussion
Supervised SIT has emerged as a strategy to improve exercise performance and health, but as with all exercise there is clear inter-individual variation in responses (Ruchat et al. 2010 ). In support of previous reports this study observed improvements in body composition ( Figure   1 ), insulin sensitivity and lipid profiles in response to SIT. Interactions with individual genetics may be a factor in individual responses to exercise (Ruchat et al. 2010 ) and D r a f t transcriptional responses of the SIRT/NAD system to SIT were investigated to determine associations with the responses to SIT in blood samples.
The sirtuin/NAD system consists of 7 sirtuin genes (SIRT1-7) and genes encoding enzymes that are involved in de novo synthesis of NAD from dietary tryptophan and vitamin B3.
Additionally, there are a number of enzymes that are involved in recycling NAD to increase and up regulate sirtuin activity in order to maintain homeostasis and respond to various stressors (Ying 2008) . This study measured blood profiles of the sirtuin/NAD system pre and post SIT to determine whether SIT led to a shift in the homeostatic sirtuin/NAD profile in each participant as opposed to focusing on acute effects of SIT. Corresponding shifts in other blood factors were considered in parallel two days post the final SIT session. Results of transcriptional profiling of blood from our volunteers indicated interactions with the sirtuin system, with small, but significant down regulation of CD38 (which depletes NAD) and up regulation of NMNAT1 and NAMPT (rate limiting enzymes in NAD synthesis) and ABCA1 (a lipid transporter that alters blood cholesterol). This evidence was further supported by correlations showing co-regulated expression of this small gene set (Table 4) . Importantly, it is now well recognised that small changes in a gene set within a biochemical pathway are often related to biologically meaningful changes (Subramanian et al. 2005) . The correlated gene expression of NAMPT, NMNAT1, CD38 and ABCA1 post SIT (Table 4) indicates that these may be key components of the sirtuin/NAD system responses to exercise training. plasma levels were observed in the study participants and were not directly correlated with expression of NAMPT in blood. This may be attributed to differences in body fat levels in the study participants as studies have indicated that extracellular NAMPT may be primarily secreted from adipose tissue rather than blood cells (Berndt et al 2005; Yoon et al. 2015) .
PCA and PLS plots ( Figure 5 ) indicated that the variation in sirtuin/NAD system responses to SIT may be attributed, in part, to sex differences. This is supported by a recent study reporting sex differences in response to 12 weeks of sprint interval training (Bagley et al. 2016 ). Additionally, it was noted that individual male participants (IDs 1, 6 and 19) appeared to respond differently to SIT in comparison with the remainder of the male cohort ( Figure 5 ). The current pilot study was not without limitations. Due to technical issues we were not able to record power output during SIT and inter-individual variations in work could contribute to some of the differences observed. However, participants were asked to give a maximal effort, as the majority of SIT interventions do and rely on. The volunteers were supervised during each session and so any major issues with effort are unlikely. The current study did not account for hormonal differences at different points in the menstrual cycle and future work should consider hormone levels. However, irrespective of potential variation in menstrual status, sirtuin/NAD blood gene expression profiles show less variation when compared to males. It seems unlikely that menstrual status has a large effect. This study did not use a control group. Hence, a comparison with a group not participating in regular SIT sessions was not possible. Responses to SIT were thus compared within individuals using pre-SIT intervention measurements for comparison with post-SIT measurements. Extending SIT studies may facilitate assessments over a period when the study subjects refrain from SIT. It is difficult to provide an appropriate comparable control group for SIT. Monitoring of physical activity levels in the group not participating in SIT would be an important factor to reduce confounding responses during the intervention period. Habitual physical activity D r a f t 20 levels were not assessed or whether these changed during the SIT period. All aspects of physical activity (not only the SIT) may alter the sirtuin/NAD system and should be considered in design of future studies.
In conclusion, significant improvements in body composition parameters (body mass and body fat) were achieved in response to SIT, but associated significant improvements in mean levels of metabolic health parameters were not observed (Supplementary File S3) . However, it was noted that although mean levels of metabolic health parameters did not reveal significant changes in response to SIT a number of participants did show improved glucose regulation and lipid profiles and associated transcriptional responses in the sirtuin/NAD system. Notably, metabolic improvements in response to SIT were achieved in individuals with poor health parameters measured pre-SIT. Furthermore, differences in female and male participants indicated that sex-specific factors may influence responses to SIT. This pilot study establishes criteria for designing future studies to investigate responses to SIT. In addition to male and female cohorts to determine sex specific effects, measurement of blood and tissue level profiles, the inclusion of a control group not undertaking increased physical activity, gathering additional data on lifestyle factors, such as habitual physical activity, will further inform interpretation of data analysis. Further investigation of the causes of the marked inter-individual variation in observed responses to SIT will be critical in formulating optimal public health messages for SIT and potentially other forms of exercise. Garten, A., Schuster, S., Penke, M., Gorski, T., de Giorgis, T., Kiess, W. 2015.
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